Dr. Kyle Gallant is a Warwick, Rhode Island based nurse practitioner. Active license number of Dr. Kyle Gallant is RN57490 in Rhode Island. His current practice location is 475 Kilvert St, Warwick. Patients can reach him at 401-732-7406 or can fax him at 855-230-1037. Dr. Kyle Gallant is DNP, AGPCNP-BC and his NPI number (Unique professional ID assigned by NPPES) is 1083107338. Dr. Kyle Gallant has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Dr. Kyle Gallant speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1083107338
NPI Enumeration Date:
12 Jun, 2018
NPI Last Update On:
12 Jun, 2018
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Kyle Gallant are as mentioned below.
License Number
Specialization
State
Status
RN57490
Rhode Island
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Kyle Gallant 64 Willow St, Fall River, Massachusetts
Zip:
02720-4626
Phone Number:
774-406-9513
Patients can reach Dr. Kyle Gallant at 475 Kilvert St, Warwick, Rhode Island or can call to book an appointment on 401-732-7406.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 April, 2025.